Equity · Healthcare
BCRX
NASDAQBioCryst Pharmaceuticals (BCRX)
Reddit mentioned BCRX 8 times in the 30 days to 21 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 75% read bullish, 0% bearish and 25% neither. Reddit data updated 21 October 2026.
The line runs $9.39 on 23 July through $8 on 20 October, on a scale from $7 to $11. Days the market did not trade hold the previous close, flat.
as of Oct 20, 2026
BioCryst Pharmaceuticals (BCRX) · crowd attention × price
Share ↗
Day13 Oct 2026
Reddit's attention on BCRX arrived in one burst — 2 of this window's 8 mentions landed on 22 September alone
BCRX drew 17 Reddit mentions over the 90 days to 21 October 2026
This chart in words
The chart plots daily Reddit mentions of BCRX over the 30 days to 21 October 2026: 8 in total, busiest on 22 September with 2, and 1 on the last day counted. The line is the daily close over the same window: $8.78 on 22 September, $8 on 20 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.
The chart plots daily Reddit mentions of BCRX over the 90 days to 21 October 2026: 17 in total, busiest on 10 September with 3, and 1 on the last day counted. The line is the daily close over the same window: $9.33 on 24 July, $8 on 20 October. Of those days, 62 were trading sessions and the other 28 are hatched on the chart. On 27 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.
BioCryst Pharmaceuticals (BCRX) on Reddit · 30d
In the 30 days to 21 Oct 2026, BioCryst Pharmaceuticals drew 8 Reddit mentions in the finance subreddits we track, 8 of them scored for sentiment.
bullish
bullish
BCRX reads 21 points more bullish than overall market sentiment. Same measure; same 30-day window.
Where BCRX is discussed
(30d)BioCryst Pharmaceuticals (BCRX) insider trades
In the 90 days to 21 Oct 2026, no BioCryst Pharmaceuticals insider bought or sold shares on the open market; all 5 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
BioCryst Pharmaceuticals (BCRX) reported financials
SEC EDGARBioCryst Pharmaceuticals reported revenue of $874.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was $263.9M.
BioCryst Pharmaceuticals (BCRX) earnings
BioCryst Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.30; no next date is announced in SEC filings yet.
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
BioCryst Pharmaceuticals (BCRX) institutional holders (13F)
SEC EDGAR12 of the 45 institutional funds we track reported a BioCryst Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined $216.2M; the latest of those filings landed 02 Sep 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
BioCryst Pharmaceuticals (BCRX) fails-to-deliver
SECOn 21 Sep 2026, 328 shares of BioCryst Pharmaceuticals failed to deliver (about $3K).
Congressional trades in BioCryst Pharmaceuticals (BCRX)
House disclosuresThe most recent congressional trade disclosed in BioCryst Pharmaceuticals is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 13 Nov 2025.
BioCryst Pharmaceuticals (BCRX): frequently asked questions
Have BioCryst Pharmaceuticals insiders bought or sold shares recently?
In the 90 days to 21 Oct 2026, no BioCryst Pharmaceuticals insider bought or sold shares on the open market; all 5 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
How many institutions hold BioCryst Pharmaceuticals?
12 of the 45 institutional funds we track reported a BioCryst Pharmaceuticals position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.
Has BioCryst Pharmaceuticals had fails-to-deliver recently?
Yes. The most recent SEC fails-to-deliver record for BioCryst Pharmaceuticals is dated 21 Sep 2026, when 328 shares failed to deliver.
When did BioCryst Pharmaceuticals last report earnings?
BioCryst Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.30; no next date is announced in SEC filings yet.
What exchange is BioCryst Pharmaceuticals listed on?
BioCryst Pharmaceuticals trades on NASDAQ under the ticker BCRX.
What is Reddit saying about BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals was mentioned 0 times in the last 7 days across the finance subreddits we track, and 8 times over the trailing 30 days. Of 8 classified mentions, 75% read bullish, 0% bearish and 25% neutral. Crowd sentiment is a social signal, not investment advice.
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- SECSEC fails-to-deliver (CNS) data
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARValuation computed from SEC EDGAR filings